List of bibliographic references
Number of relevant bibliographic references: 3.
List of associated KwdEn.i
Nombre de documents | Descripteur |
2 | AS, ankylosing spondylitis |
2 | Ankylosing |
2 | Ankylosing spondylitis |
2 | Arthritis |
2 | Arthritis rheum |
2 | Asas |
2 | Axial |
2 | Biological agents |
2 | Calin |
2 | Chronic |
2 | Dougados |
2 | Enthesitis |
2 | Heijde |
2 | NSAIDs, non-steroidal anti-inflammatory drugs |
2 | Nsaid |
2 | Past week |
2 | Peripheral arthritis |
2 | Rheum |
2 | Rheumatoid arthritis |
2 | Rheumatol |
2 | Rheumatology |
2 | Spondylitis |
2 | Tumour necrosis factor |
2 | VAS, visual analogue scale |
2 | ankylosing spondylitis |
1 | ASAS |
1 | ASAS Working Group |
1 | ASAS, ASsessment in AS |
1 | ASAS, ASsessment in Ankylosing Spondylitis |
1 | Active ankylosing spondylitis |
1 | Active disease |
1 | Adverse effects |
1 | Andersson lesion |
1 | Antibody infliximab |
1 | Antinuclear antibodies |
1 | Antirheumatic agent |
1 | Antirheumatic drugs |
1 | Antirheumatic treatment |
1 | Arthroplasty |
1 | Asas core |
1 | Asas members |
1 | Asas recommendations |
1 | Axial disease |
1 | Axial involvement |
1 | BASFI, Bath Ankylosing Spondylitis Functional Index |
1 | Basfi |
1 | Bath ankylosing spondylitis |
1 | Beneficial effect |
1 | Best evidence |
1 | Biological agent |
1 | Biological treatment |
1 | Blocker |
1 | Braun |
1 | CI, confidence interval |
1 | CRP, C reactive protein |
1 | Cardiovascular |
1 | Cardiovascular events |
1 | Chemotherapy |
1 | Chest expansion |
1 | Clinical experience |
1 | Clinical expertise |
1 | Clinical findings |
1 | Clinical parameters |
1 | Clinical presentation |
1 | Clinical record |
1 | Clinical response |
1 | Clinical trials |
1 | Cochin hospital |
1 | Cochrane database syst |
1 | Comparative studies |
1 | Composite index |
1 | Concomitant |
1 | Concomitant drugs |
1 | Confidence interval |
1 | Congestive heart failure |
1 | Continuous treatment |
1 | Conventional treatments |
1 | Corrective osteotomy |
1 | Corticosteroid |
1 | Corticosteroid injections |
1 | Cost effectiveness |
1 | Coxibs |
1 | Current manifestations |
1 | Current symptoms |
1 | DC-ART, disease controlling antirheumatic treatment |
1 | DMARDs, disease modifying antirheumatic drugs |
1 | Delphi |
1 | Delphi exercise |
1 | Delphi study |
1 | Delphi technique |
1 | Descartes university |
1 | Disease activity stiffness pain |
1 | Disease monitoring |
1 | Disease progression |
1 | Dmards |
1 | Drug treatment |
1 | ES, effect size |
1 | ESR, erythrocyte sedimentation rate |
1 | EULAR |
1 | Effect size |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/UK/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "M A Khan"
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i \
-Sk "M A Khan" \
| HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= UK
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= M A Khan
}}
| This area was generated with Dilib version V0.6.33. Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 | ![](Common/icons/LogoDilib.gif) |